scholarly journals Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector

2010 ◽  
Vol 8 (4) ◽  
pp. 282-298 ◽  
Author(s):  
Rosamund Chapman ◽  
Gerald Chege ◽  
Enid Shephard ◽  
Helen Stutz ◽  
Anna-Lise Williamson
Keyword(s):  
Mycobacterium Bovis ◽  
Hiv Vaccine ◽  
Vaccine Vector ◽  
Mycobacterium Bovis Bcg

Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned

2018 ◽  
Vol 17 (11) ◽  
pp. 1005-1020 ◽  
Author(s):  
Athina Kilpeläinen ◽  
Milena Maya-Hoyos ◽  
Narcís Saubí ◽  
Carlos Y. Soto ◽  
Joan Joseph
Keyword(s):  
Mycobacterium Bovis ◽  
Vaccine Development ◽  
Lessons Learned ◽  
Hiv Vaccine ◽  
Mycobacterium Bovis Bcg

scholarly journals Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model

2013 ◽  
Vol 87 (9) ◽  
pp. 5151-5160 ◽  
Author(s):  
G. K. Chege ◽  
W. A. Burgers ◽  
H. Stutz ◽  
A. E. Meyers ◽  
R. Chapman ◽  
...  
Keyword(s):  
Mycobacterium Bovis ◽  
Nonhuman Primate ◽  
Vaccine Candidate ◽  
Hiv Vaccine ◽  
Nonhuman Primate Model ◽  
Primate Model ◽  
Mycobacterium Bovis Bcg

scholarly journals Anti-dormant Mycobacterial Activity of Viomellein and Xanthomegnin, Naphthoquinone Dimers Produced by Marine-derived Aspergillus sp

2017 ◽  
Vol 12 (4) ◽  
pp. 1934578X1701200
Author(s):  
Kentaro Kamiya ◽  
Masayoshi Arai ◽  
Andi Setiawan ◽  
Motomasa Kobayashi
Keyword(s):  
Mycobacterium Bovis ◽  
Plasmid Dna ◽  
Active Fraction ◽  
Mycobacterium Bovis Bcg ◽  
Mycobacterial Genome ◽  
Weak Activity ◽  
Aspergillus Sp ◽  
Chelating Effect

In the course of a search for anti-dormant mycobacterial substances from marine-derived microorganisms, viomellein (1) and xanthomegnin (2) were rediscovered from the active fraction of the culture of a marine-derived Aspergillus sp. together with rubrosulphin (3) and asteltoxin (4) on the guidance of bioassay-guided separation. In particular, compound 1 showed higher activity against the dormant than against actively growing Mycobacterium bovis BCG and weak activity against M. smegmatis. Furthermore, evidence that compound 1 did not directly bind to plasmid DNA suggests its anti-mycobacterial activity differs from its direct chelating effect on the mycobacterial genome.

Severe Mycobacterium bovis BCG infections in a large series of novel IL–12 receptor β1 deficient patients and evidence for the existence of partial IL–12 receptor β1 deficiency

2003 ◽  
Vol 33 (1) ◽  
pp. 59-69 ◽  
Author(s):  
Elgin G. R. Lichtenauer-Kaligis ◽  
Tjitske de Boer ◽  
Frank A. W. Verreck ◽  
Sjaak van Voorden ◽  
Marieke A. Hoeve ◽  
...  
Keyword(s):  
Mycobacterium Bovis ◽  
Large Series ◽  
Mycobacterium Bovis Bcg

Characterisation of a lipoprotein in Mycobacterium bovis (BCG) with sequence similarity to the secreted protein MPB70

Gene ◽  
1997 ◽  
Vol 188 (1) ◽  
pp. 123-128 ◽  
Author(s):  
Wilna Vosloo ◽  
Patrick Tippoo ◽  
Jane E Hughes ◽  
Natalie Harriman ◽  
Malcolm Emms ◽  
...  
Keyword(s):  
Mycobacterium Bovis ◽  
Sequence Similarity ◽  
Secreted Protein ◽  
Mycobacterium Bovis Bcg
Sign in / Sign up

Export Citation Format

Share Document